Advertisement

Topics

Iconic Therapeutics, Inc. Company Profile

00:59 EST 15th November 2018 | BioPortfolio

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal disease and cancer. The company’s lead product candidate, ICON-1, is a novel fusion protein designed to address the basis of vision loss in AMD. By targeting inflammation and angiogenesis together, ICON-1 may potentially alter the course of this leading cause of blindness. Iconic has completed a Phase 1 clinical trial in wet AMD and has initiated a Phase 2 study in newly diagnosed AMD patients. The company is investigating the ICON family of proteins in cancer and has initiated a research program in solid tumors. Iconic is backed by leading venture capital firms MPM Capital, H.I.G. Bioventures and Lundbeckfond Ventures. Please visit www.iconictherapeutics.com for additional information.


News Articles [790 Associated News Articles listed on BioPortfolio]

Jounce Therapeutics Presents Preliminary Efficacy Data from Ongoing Phase 1/2 ICONIC Trial of JTX-2011 in Patients with Advanced Cancers

CAMBRIDGE, Mass., June 02, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and pr...

Jounce Therapeutics to Present Data from Ongoing ICONIC Trial of JTX-2011 at the 2018 American Society of Clinical Oncology Annual Meeting

ICONIC Target Enrollment Met Across Four Combination Cohorts Company to Host Investor Event and Live Webcast on Monday, June 4 CAMBRIDGE, Mass., May 16, 2018 (GLOBE NEWSWIRE) --  Jounce Therape...

Results from the phase I ICONIC trial

Dr Yap speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about data from the ICONIC trial of ICOS agonist antibody JTX-2011, a first-in-class drug. He outlin...

The physician’s white coat: Iconic and comforting or likely covered in germs?

A new study from The University of Texas Medical Branch at Galveston department of Obstetrics and

Allergan Buys Bonti, Releases New Data In Defense Of 'Iconic' Botox Brand

Allergan declared that no other brand is more 'iconic' than Botox, during its medical aesthetics investor event, but the company...    

Fetzer Vineyards Adds Excelsior Wines To Portfolio

Fetzer Vineyards' Expanded Offerings Encompass Iconic South American Selections The Excelsior portfolio includes iconic South American wine brands such as Chile'smost-acclaimed wine, Don Melchor ...

The physician's white coat: Iconic and comforting or likely covered in germs?

(University of Texas Medical Branch at Galveston) A new study from The University of Texas Medical Branch at Galveston has found that although the physicians' white coat is one of the most iconic symb...

Japan's iconic extinct mammal: A sleeping treasure in a university collection

(University of Tsukuba) After more than 60 years, the bone of an iconic extinct Japanese mammal has been rediscovered by a team of researchers led by the University of Tsukuba. With the help of an old...

PubMed Articles [489 Associated PubMed Articles listed on BioPortfolio]

Natural Reference: A phylo- and ontogenetic perspective on the comprehension of iconic gestures and vocalizations.

The recognition of iconic correspondence between signal and referent has been argued to bootstrap the acquisition and emergence of language. Here we study the ontogeny, and to some extent the phylogen...

Corrigendum: Iconic Memories Die a Sudden Death.

A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.

This phase 1 study evaluated the safety and tolerability of single intravitreous injections (IVIs) of ICON-1 (Iconic Therapeutics, South San Francisco, CA) in patients with neovascular age-related mac...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

Clinical Trials [165 Associated Clinical Trials listed on BioPortfolio]

Cognitive Skills and Iconic Gestures

In this study, cognitive skills will be identified that underlie the production of iconic gestures in individuals with language difficulties. Specifically, what is the role of nonverbal se...

Effectiveness of the Iconic Therapy for Borderline Personality Disorder Symptoms

Borderline personality disorder (BPD) is the most prevalent personality disorder in young community population whose most severe complication is suicide. Pharmacotherapy should not be used...

Accuracy of Commercially Available Heart Rate Monitors in Athletes

The purpose of this research is to compare four different heart rate monitors (Apple Watch Nike III,Fitbit Iconic, Garmin Vivosmart HR, Tom Tom Spark 3) to an Electrocardiograph (ECG) mach...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [1307 Associated Companies listed on BioPortfolio]

Iconic Therapeutics, Inc.

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal di...

Iconic Therapeutics

Iconic Therapeutics is a clinical stage biopharmaceutical company dedicated to translating an understanding of the role of Tissue Factor biology to new therapeutics for retinal di...

ICONIC Protein

ICONIC Protein is one of the fastest-growing brands in the ready-to-drink protein beverage market with a passionate following of health-conscious consumers who have flocked to the...

Iconic Brands Inc.

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Iconic Therapeutics, Inc." on BioPortfolio

We have published hundreds of Iconic Therapeutics, Inc. news stories on BioPortfolio along with dozens of Iconic Therapeutics, Inc. Clinical Trials and PubMed Articles about Iconic Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Iconic Therapeutics, Inc. Companies in our database. You can also find out about relevant Iconic Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record